Results 31 to 40 of about 1,524 (178)

Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy

Medicina, 2021
Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC).
Michał Chrząszcz, Weronika Pociej-Marciak, Katarzyna Żuber-Łaskawiec, Bożena Romanowska-Dixon, Marek Sanak, Katarzyna Michalska-Małecka, Mojca Globočnik Petrovič, Izabella Karska-Basta   +7 more
doaj   +1 more source

Neovascular glaucoma in atypical central serous chorioretinopathy and pachychoroid disease

Indian Journal of Ophthalmology. Case Reports, 2022
We report an atypical central serous chorioretinopathy (CSCR) with pachychoroid disease and consequent recalcitrant neovascular glaucoma (NVG). A 45-year-old man with persistent subretinal fluid, pachychoroid and bilateral large areas of capillary ...
Aparna Rao, Srikanta Kumar Padhy
doaj   +1 more source

Pachychoroid, an update from the new finding to the usual investigation in selected diseases

Revista Brasileira de Oftalmologia
The authors make an update of pachychoroid in a group of the choroidal-retinal diseases that choroidal thickening is an usualenhanced depth image - optic coherence tomography (EDI-OCT) finding like as central serous chorioretinopathy, pachychoroid ...
Miguel Hage Amaro, Jorge Mitre, Mario Martins dos Santos Motta, João Jorge Nassaralla Junior, Teruo Aihara   +4 more
doaj   +1 more source

An eye on long‐duration spaceflight: Controversies, countermeasures and challenges

Experimental Physiology, EarlyView.
Abstract Space flight‐associated neuroocular syndrome (SANS) is a consequence of long‐duration space flight and is detected in two‐thirds of astronauts. In‐flight, this can cause a change in the refraction of the eyes, requiring graded hypermetropic ‘superfocus adjustable’ glasses, optic nerve head oedema and choroidal folds.
Vincent Wing Sum Ng, Susan Patricia Mollan   +1 more
wiley   +1 more source

Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4

Acta Ophthalmologica, Volume 104, Issue 5, Page e565-e577, August 2026.
Abstract Purpose Assessing the 24‐month treatment outcome of half‐dose photodynamic therapy (PDT) or oral eplerenone in chronic central serous chorioretinopathy (cCSC). Methods Multicentre randomized clinical trial included cCSC patients from the SPECTRA trial who were randomized to receive half‐dose PDT or oral eplerenone.
Helena M. A. Feenstra, Issam El Mansori, Thomas J. van Rijssen, Roula Tsonaka, Roselie M. H. Diederen, Carel B. Hoyng, Reinier O. Schlingemann, Camiel J. F. Boon, Elon H. C. van Dijk   +8 more
wiley   +1 more source

The prechoroidal cleft in neovascular age‐related macular degeneration

Acta Ophthalmologica, Volume 104, Issue 4, Page 364-375, June 2026.
Abstract The prechoroidal cleft is a lenticular, hypo‐reflective space on optical coherence tomography imaging, located between a band of fibrovascular material underneath the retinal pigment epithelium (RPE) and Bruch's membrane. It occurs in 8%–22% of neovascular age‐related macular degeneration (nAMD) eyes, most often with macular neovascularization
Niels J. Brouwer, T. H. Khanh Vu, Yvonne De Jong‐Hesse, Elon H. C. van Dijk   +3 more
wiley   +1 more source

Updated review of the pachychoroid spectrum and central serous chorioretinopathy [PDF]

Revista Brasileira de Oftalmologia
The pachychoroid disease spectrum (PDS) encompasses a range of chorioretinal disorders characterized by increased choroidal thickness, dilated Haller's layer vessels (pachyvessels), and choroidal hyperpermeability, often associated with retinal pigment ...
Heitor Santos Nogueira, Mateus Pimenta Arruda, João Pedro Romero Braga, José Augusto Cardillo, Luiz H. Lima   +4 more
doaj   +1 more source

Pachychoroid disease: review and update

Eye
Abstract The pachychoroid disease spectrum is a phenotype characterized by alterations in choroidal vasculature which result in outer retinal and choriocapillaris damage and visual loss. The presence of pachyvessels is one of the key features of the pachychoroid phenotype.
Chui Ming Gemmy Cheung, Kunal K. Dansingani, Hideki Koizumi, Timothy Y. Y. Lai, Sobha Sivaprasad, Camiel J. F. Boon, Elon H. C. Van Dijk, Jay Chhablani, Won Ki Lee, K. Bailey Freund   +9 more
openaire   +4 more sources

Seasonal variation in the incidence of central serous chorioretinopathy: A systematic review and meta‐analysis

Acta Ophthalmologica, Volume 104, Issue 4, Page 355-363, June 2026.
Abstract Central serous chorioretinopathy (CSC) is a chorioretinal disease characterised by serous subretinal fluid (SRF) in the macula, resulting in sudden central vision loss. It predominantly affects working‐age adults, particularly men aged 30 to 60 years.
I. Made Ferdiko Hutamadella, Emil Ørnberg, Mark P. Breazzano, Lasse Jørgensen Cehofski, Chui Ming Gemmy Cheung, Kristina Pfau, M. Cem Sabaner, Lorenzo Ferro Desideri, Camiel J. F. Boon, Yousif Subhi, Elon H. C. van Dijk   +10 more
wiley   +1 more source

Association of IL-4 with pachychoroid neovasculopathy

Scientific Reports, 2022
Abstract The purpose of this study was to identify inflammatory cytokines that are associated with pachychoroid neovasculopathy (PNV). Seventy-five eyes of 75 patients with PNV, 145 eyes of 145 patients with neovascular age-related macular degeneration without pachyvessels, and 150 eyes of 150 normal subjects were examined for the levels of ...
Takashi Baba, Ayumi Koyama, Ryu Uotani, Hitomi Miyake, Kodai Inata, Shin-ichi Sasaki, Yumiko Shimizu, Yoshitsugu Inoue, Kaori Adachi, Eiji Nanba, Dai Miyazaki   +10 more
openaire   +3 more sources